NDC 68788-9255

bupropion

Bupropion

bupropion is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Preferred Pharmaceuticals, Inc.. The primary component is Bupropion Hydrochloride.

• Product ID: 68788-9255_114736f0-0819-4541-b265-0461d873e90e
• NDC: 68788-9255
• Product Type: Human Prescription Drug
• Proprietary Name: bupropion
• Generic Name: Bupropion
• Dosage Form: Tablet, Extended Release
• Route of Administration: ORAL
• Marketing Start Date: 2014-11-03
• Marketing Category: ANDA / ANDA
• Application Number: ANDA201567
• Labeler Name: Preferred Pharmaceuticals, Inc.
• Substance Name: BUPROPION HYDROCHLORIDE
• Active Ingredient Strength: 300 mg/1
• Pharm Classes: Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 68788-9255-9

90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-9255-9)

• Marketing Start Date: 2014-11-03
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 68788-9255-9 [68788925509]

bupropion TABLET, EXTENDED RELEASE

• Marketing Category: ANDA
• Application Number: ANDA201567
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2014-11-03
• Marketing End Date: 2019-06-28

NDC 68788-9255-3 [68788925503]

bupropion TABLET, EXTENDED RELEASE

• Marketing Category: ANDA
• Application Number: ANDA201567
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2014-11-03
• Marketing End Date: 2019-06-28

NDC 68788-9255-1 [68788925501]

bupropion TABLET, EXTENDED RELEASE

• Marketing Category: ANDA
• Application Number: ANDA201567
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2014-11-03
• Marketing End Date: 2019-06-28

NDC 68788-9255-8 [68788925508]

bupropion TABLET, EXTENDED RELEASE

• Marketing Category: ANDA
• Application Number: ANDA201567
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2014-11-03
• Marketing End Date: 2019-06-28

NDC 68788-9255-6 [68788925506]

bupropion TABLET, EXTENDED RELEASE

• Marketing Category: ANDA
• Application Number: ANDA201567
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2014-11-03
• Marketing End Date: 2019-06-28

Drug Details

Active Ingredients

Ingredient	Strength
BUPROPION HYDROCHLORIDE	300 mg/1

OpenFDA Data

• SPL SET ID: f9378e0d-f502-4f8c-b953-713e4b36cf02
• Manufacturer:
  • Preferred Pharmaceuticals, Inc.
• UNII:
  • ZG7E5POY8O
• RxNorm Concept Unique ID - RxCUI:
  • 993557

Pharmacological Class

• Aminoketone [EPC]
• Dopamine Uptake Inhibitors [MoA]
• Increased Dopamine Activity [PE]
• Increased Norepinephrine Activity [PE]
• Norepinephrine Uptake Inhibitors [MoA]

NDC Crossover Matching brand name "bupropion" or generic name "Bupropion"

NDC	Brand Name	Generic Name
0615-8262	bupropion	bupropion hydrochloride
43547-288	bupropion	Bupropion hydrochloride
43547-289	bupropion	bupropion hydrochloride
43547-290	bupropion	bupropion hydrochloride
50090-3854	bupropion	bupropion hydrochloride
50436-0289	bupropion	bupropion hydrochloride
51655-357	bupropion	bupropion hydrochloride
54868-5927	Bupropion	bupropion hydrochloride
55700-644	bupropion	bupropion hydrochloride
63187-521	bupropion	bupropion
63629-8036	bupropion	bupropion hydrochloride
65841-780	bupropion	bupropion
65841-836	bupropion	bupropion
67046-699	Bupropion	Bupropion
68001-264	bupropion	bupropion
68071-5214	bupropion	bupropion hydrochloride
68382-353	bupropion	bupropion
68382-354	bupropion	bupropion
68788-7249	bupropion	bupropion
68788-9255	bupropion	bupropion
70518-1644	bupropion	bupropion
71335-0801	bupropion	bupropion
71335-0785	bupropion	bupropion
70934-151	bupropion	bupropion
68788-7283	bupropion	bupropion
70518-2641	bupropion	bupropion
71335-1622	bupropion	bupropion